Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2012; 18(27): 3502-3510
Published online Jul 21, 2012. doi: 10.3748/wjg.v18.i27.3502
Published online Jul 21, 2012. doi: 10.3748/wjg.v18.i27.3502
Table 1 Human Reg family
Superfamily member | Length of amino acid | Chromosome localization | Main function |
RegIA | 166 | 2p12 | Islet cell regeneration, diabetogenesis and pancreatic lithogenesis |
RegIB | 166 | 2p12 | Islet cell regeneration, diabetogenesis and pancreatic lithogenesis |
RegIIIA | 175 | 2p12 | Cell proliferation and differentiation in pancreatic inflammation and liver carcinogenesis |
RegIIIG | 175 | 2p12 | Lectin-mediated innate immunity by binding intestinal bacteria, forming symbiotic host-microbial relationships |
RegIV | 158 | 1p12 | Cell proliferation and cell regeneration. Carcinogenesis and anti-apoptosis in gastroenterological cancers |
Table 2 Articles reporting regenerating islet-derived type IV as anti-apoptic factor
Author | Year | Type of cancer | Result |
Bishnupuri et al[46] | 2006 | Colorectal | RegIV induces cell survival against radiation, and regulates Bcl-2 and Bcl-xL |
Mitani et al[19] | 2007 | Gastric | RegIV inhibited 5-fluorouracil-induced apoptosis, and induced DPD expression |
Eguchi et al[44] | 2009 | Pancreatic | RegIV decreased the sensitivity to radiation and gemcitabine |
Table 3 Articles reporting regenerating islet-derived type IV as biomarker
Author | Year | Type of cancer | Result |
Oue et al[18] | 2007 | Colorectal | Serum RegIV concentration was significantly elevated in patients with liver metastases than those without |
Mitani et al[19] | 2007 | Gastric | Presurgical serum RegIV was significantly elevated compared with healthy individuals |
Kobayashi et al[59] | 2010 | Gastric | Presurgical serum RegIV was significantly different in early and advanced cancer, compared with healthy individuals |
Table 4 Articles reporting regenerating islet-derived type IV-targetted therapy
Author | Year | Method/type of cancer | Result |
Bishunpuri et al[53] | 2006 | Transfection of rhR4/colorectal | Increase in pEGFR and pAkt |
Takehara et al[20] | 2006 | Transfection of rhR4 and siRNA/pancreatic | Significant reduction in viable cells andincrease in pAkt |
Legoffic et al[72] | 2009 | RegIV antibody injection/pancreatic | Significant reductions in Akt, Bcl-2 and Bcl-xL |
- Citation: Numata M, Oshima T. Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers. World J Gastroenterol 2012; 18(27): 3502-3510
- URL: https://www.wjgnet.com/1007-9327/full/v18/i27/3502.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i27.3502